Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.10
+0.108010.89%
Post-market: 1.100.00000.00%19:59 EDT
Volume:165.63M
Turnover:264.20M
Market Cap:69.26M
PE:-0.92
High:1.89
Open:1.89
Low:1.07
Close:0.9920
52wk High:3.82
52wk Low:0.9800
Shares:62.96M
Float Shares:21.58M
Volume Ratio:117.28
T/O Rate:767.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:2.58
PE(LYR):-1.10

Loading ...

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Alkermes (ALKS) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Jun 18

Connect Biopharma Completes Enrollment in Phase 2 Rademikibart Asthma Study

MT Newswires Live
·
Jun 17

Connect Biopharma - to Report Topline Data From Seabreeze Stat Asthma Study in Early September 2026

THOMSON REUTERS
·
Jun 17

Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze Stat Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

THOMSON REUTERS
·
Jun 17

H.C. Wainwright Reaffirms Their Buy Rating on Connect Biopharma Holdings (CNTB)

TIPRANKS
·
May 27

Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target

MT Newswires Live
·
May 26

Connect Biopharma initiated with a Buy at Canaccord

TIPRANKS
·
May 26

Connect Biopharma Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
May 21

Connect Biopharma initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
May 21

Connect Biopharma files to sell 6.13M ordinary shares for holders

TIPRANKS
·
May 15

Connect Biopharma Holdings Ltd - Proposed Resale of up to 6.1 Mln Ordinary Shares of Connect Biopharma - SEC Filing

THOMSON REUTERS
·
May 15

Connect Biopharma posts corporate presentation on rademikibart development in asthma, COPD, atopic dermatitis

Reuters
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 13

Connect Biopharma Hldgs Q1 EPS $(0.34) Misses $(0.28) Estimate, Sales $169.000K

Benzinga Earnings
·
May 12

Connect Biopharma Holdings Ltd: Currently Remain on Track to Report Topline Results From Both Seabreeze Stat Studies Mid-Year

THOMSON REUTERS
·
May 12

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 12

Simcere says China regulator accepts NDA for atopic dermatitis drug rademikibart

Reuters
·
Apr 30

Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 24

Connect Biopharma Holdings Ltd - Expects to Report Phase 2 Seabreeze Stat Topline Data in Mid-2026

THOMSON REUTERS
·
Apr 23